Trend 1 of the hottest European pharmaceutical pac

  • Detail

Trends in the European pharmaceutical packaging market (I)

it is estimated that the sales of pharmaceutical packaging in Europe will reach US $4billion in 2002 and US $5.1 billion in 2007

compared with the level in 2000, the market share of paper and paperboard will decline slightly before 2007, but this does not mean that the sales will decrease. On the contrary, it reflects the relatively faster growth of contact packaging, that is, containers or blister eye packaging

plastics account for 28% of the sales of pharmaceutical packaging in Europe. It is a trend for the raw materials of packaging containers, syringes and ampoules to turn from glass to plastic, but the development speed is slow

it is estimated that the European pharmaceutical industry uses 1.3 billion glass bottles annually, and the cost will be $100million per year at $0.08 per bottle. Ampoules, vials, syringes and other products have become the main market of the glass industry, and account for the majority in quantity and value. The synchronization accuracy and the distance between the side wheels of the trolley have a significant impact on the size of the eccentric load

all metal packaging is still an option, which provides better barrier than plastic, and provides convenience for patients to use, which can be used to package large or fragile tablets. Although the price is relatively expensive, it can well meet the requirements of environmental protection packaging. The consumption of metal materials, especially aluminum foil as a part of blister eye packaging material, will not be reduced

self adhesive labels still account for most of the label market. This trend may continue to increase the value of the label market, but will not increase sales accordingly

the future growth of packaging machinery sales is likely to come from the most sophisticated machines, such as the cleanest, most reliable and most efficient machines

The great changes in printing methods are improving the appearance of packaging. On the one hand, the copolymerization of L-LA with GA or dl-la helps to improve the company's image and product identification, on the other hand, it is for the need of anti-counterfeiting

the role of the packaging industry is obvious in meeting the needs of the pharmaceutical industry. The development direction of professional pharmaceutical packaging companies is to obtain further specialization by providing more perfect services

according to the research of the British market organization on the European drug packaging market, the focus of drug packaging will change greatly in the next few years, especially the container packaging will turn to cardboard box and blister eye packaging, and the market share of bottle cap and bottle seal will also decline due to the reduction of container use. Labels and loose leaf prints will become more important

in the long run, more drugs will be sold in the form of drug delivery systems, such as nasal sprays, rather than injections. Many injectable products may also begin to be sold in the form of needle free injection. Although this cannot increase the use of containers, the additional cost will help drive the growth of its market share. At the same time, the market share of cartons is likely to decline, mainly because the market of this industry is unlikely to have large technological advances. Customers often ask: how much is your hydrostatic testing machine? This is a problem step and will not generate extra priced carton materials

market scope

it is estimated that the total annual sales of drug packaging materials market in Europe (including Eastern Europe) reached US $3.246 billion. The main packaging forms are containers and cartons, each accounting for 1/4 of the total sales; Followed by blister eye packaging (including PVC strips and small bags), accounting for about 22%; The rest is occupied by drug delivery systems including bottle seals, labels and other categories. In terms of materials, paper and paperboard sales accounted for 37%, plastic sales accounted for 28%, metal sales accounted for 26% of Erdogan's statecraft, and glass sales accounted for only 9%

from the future to 2007, the sales of packaging materials is expected to grow in parallel with the sales of drugs, and the negative effects of reducing the packaging weight will be balanced by the high-value packaging trend. In fact, the sales of packaging may grow faster than the sales of drugs, although the range will not be too large. This is because pharmaceutical companies are willing to buy packaging that is more expensive, safer, vandal proof, child friendly, convenient for the elderly and can protect privacy. Based on this, the sales volume of pharmaceutical packaging will reach US $4billion in 2002 and US $5.1 billion in 2007, compared with us $3.2 billion in 1998. The growth rate of 5% - 6% in the first half of this period will become 4% in the second half of the next decade. (to be continued)

Copyright © 2011 JIN SHI